{
    "name": "cyclopentolate",
    "comment": "Rx",
    "other_names": [
        "Cyclogyl",
        "AK-Pentolate"
    ],
    "classes": [
        "Cycloplegics/Mydriatics",
        "Anticholinergic Agents",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/cyclogyl-ak-pentolate-cyclopentolate-343613",
    "pregnancy": {
        "common": [
            "Animal reproduction studies have not been conducted; not known whether cyclopentolate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; administer to a pregnant woman only if clearly needed"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether this drug is excreted in human milk; because many drugs are excreted in human milk, exercise caution when drug is administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to drug or components"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Remove contact lenses prior to administration and wait 15 min before reinserting",
                "The elderly may be predisposed to increased intraocular pressure",
                "Mydriatics may produce transient elevation of intraocular pressure; patients with untreated narrow-angle glaucoma or anatomically narrow angles may be susceptible to angle-closure following administration",
                "Dropper tip is not to touch any surface, as this may contaminate the solution",
                "A transient burning sensation may occur upon instillation",
                "Patients should be advised not to drive or engage in other hazardous activities while pupils are dilated",
                "Patients may experience sensitivity to light and should protect eyes in bright illumination during dilation",
                "Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration",
                "Feeding intolerance may follow ophthalmic use of this product in infants; it is recommended that feeding be withheld for 4 hours after examination",
                " "
            ],
            "specific": [
                {
                    "type": "CNS effects",
                    "description": [
                        "May cause central nervous system (CNS) disturbances, especially in younger age groups but may occur at any age, especially with stronger solutions",
                        "Infants are especially prone to CNS and cardiopulmonary side effects; to minimize absorption, use only 1 drop of 0.5% solution per eye, followed by pressure applied over nasolacrimal sac for two to three minutes; observe infants closely for at least 30 minutes following instillation"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Burning sensation in eye",
            "percent": null
        },
        {
            "name": "Light intolerance",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Raised intraocular pressure",
            "percent": null
        },
        {
            "name": "Hyperreactive response in Down",
            "percent": null
        },
        {
            "name": "s syndrome children",
            "percent": null
        },
        {
            "name": "atropine",
            "percent": null
        },
        {
            "name": "Drowsiness",
            "percent": null
        }
    ]
}